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During 2009 Intensive Care Medicine has published
several articles analyzing different aspects of mechanical
ventilation and respiratory mechanics, acute lung injury
(ALI), and acute respiratory distress syndrome (ARDS).
Effects of drugs and maneuvers
Several papers have evaluated the respiratory effects of
speciﬁc maneuvers or drugs on ventilatory pattern. Wu
et al. [1] proposed that higher airway occlusion pressure
(P0.1) responses to hypercapnic challenge (HC) may
indicate less severe injury. Their study aim was to
determine whether P0.1 responses to HC were associated
with successful weaning after prolonged mechanical
ventilation (PMV) in 42 patients with brainstem lesions.
Breathing parameters and P0.1 were measured before HC.
Three-minute HC challenges with increasing CO2 con-
centrations were initiated, and P0.1, respiratory rate,
minute ventilation (VE), tidal volume (VT), and end-tidal
CO2 were measured. Patients were classiﬁed into high
(group I) and low (group II) response groups on the basis
of P0.1 responses to HC. VE and VT increases after HC
were signiﬁcantly greater in group I. P0.1 levels were
signiﬁcantly higher in group I compared with in group II
before HC. The increase in P0.1 following HC was sig-
niﬁcantly greater in group I compared with group II
patients. Weaning success was signiﬁcantly higher in
group I compared with group II patients (72.2% versus
33.3%, P = 0.02). The authors concluded that assessing
the P.01 response to serial increases of HC levels may be
a safe means to ascertain whether patients with brainstem
lesions are ready for ventilator weaning.
The respiratory, metabolic, and hemodynamic effects
of clonidine in ventilated patients presenting with with-
drawal syndrome have been evaluated by Liatsi et al. [2].
After sedation interruption, metabolic oxygen consump-
tion (VO2), CO2 production (VCO2), resting energy
expenditure (REE), minute ventilation (VE), tidal volume
(VT), respiratory rate (RR), and hemodynamic parameters
[heart rate (HR), systolic arterial pressure (SAP), mean
arterial pressure (MAP)] were measured in 30 ventilated
intensive care unit (ICU) patients. Measurements were
performed ﬁrst under sedation with remifentanil-propofol,
then after sedation interruption, and ﬁnally after clonidine
administration (0.9–1.8 mg clonidine in two doses of
10 min interval). Sedation interruption produced signiﬁ-
cant increases in SAP and MAP by 33%, HR by 37%, and
metabolic rate (increase in VO2 by 70%, VCO2 by 88%,
and REE by 74%), leading to high respiratory demands
(increase in VE from 9 to 15 l/min). VE was increased due
to a twofold increase in RR; VT remained constant. In 25
out of 30 patients, clonidine administration decreased the
hemodynamic metabolic and respiratory parameters to
values close to those observed with sedation. The authors
concluded that, in patients with withdrawal syndrome,
clonidine signiﬁcantly decreased the elevated hemody-
namic, metabolic, and respiratory demands occurring
after suspension of sedative drugs, inducing mild sedation
and facilitating patient cooperation with ventilation and
weaning.
The effects of remifentanil-propofol analgosedation on
duration of ventilation and length of ICU stay (compared
with a conventional regimen) have been evaluated by
Rozendaal et al. [3] in 15 Dutch hospitals, showing that,
in patients with expected short duration of mechanical
ventilation (MV), remifentanil signiﬁcantly improved
sedation and agitation levels and reduced weaning time.
Noninvasive ventilation
Several study have been dedicated to the clinical use of
noninvasive ventilation (NIV) in the ICU setting.
Cosentini et al. [4] assessed the outcome of 454 con-
secutive acute cardiogenic pulmonary edema (ACPE)
patients in an observational, retrospective study. Potential
predictors of in-hospital mortality considered of clinical
relevance and immediately accessible on admission were
investigated by multivariable logistic regression. ACPE-
related mortality rate was 3.8% (17/452 patients), and the
in-hospital mortality rate was 11.4% (50/440 patients).
Signiﬁcant independent predictors of increased risk of
in-hospital mortality were advanced age (P = 0.012),
normal to low blood pressure (P\0.001), low PaO2/FiO2
ratio (P = 0.020), hypocapnia (P = 0.009), and anemia
(P = 0.05).
The predictive factors of NIV failure in critically ill
children have been evaluated by Mayordomo-Colunga
et al. [5] in a group of 116 patients. Respiratory rate, heart
rate, and FiO2 before NIV, and expiratory and support
pressures were collected at 1, 6, 12, 24, and 48 h. Factors
predicting NIV failure were determined by multivariate
analysis. NIV success rate was 84.5%. Higher pediatric
risk of mortality (PRISM) score [odds ratio (OR) 1.138;
95% conﬁdence interval (CI), 1.022–1.267] and lower RR
decrease at 1 h and at 6 h (OR 0.926; 95% CI, 0.860–
0.997 and OR 0.911; 95% CI, 0.837–0.991, respectively)
were independently associated with NIV failure.
Use of NIV for acute respiratory failure (ARF) after
lung resection has been investigated by Lefebvre et al.
[6]. Of the 690 patients at risk of severe complications
following lung resection, 113 (16.3%) experienced ARF.
NIV was used in 89 (78.7%), including 59 with hypox-
emic ARF (66.3%) and 30 with hypercapnic ARF
(33.7%). The overall success rate of NIV was 85.3%
(76/89). ICU mortality was 6.7% (6/89). The mortality
rate following NIV failure was 46.1%. Predictive factors
of NIV failure in univariate analysis were age (P =
0.046), previous cardiac comorbidities (P = 0.0075),
568postoperative pneumonia (P = 0.0016), admission to the
surgical ICU (P = 0.034), no initial response to NIV
(P\0.0001), and occurrence of noninfectious compli-
cations (P = 0.037).
The role of alternative interfaces for continuous
positive airway pressure (CPAP) and NIV has been
evaluated by Foti et al. [7], who used helmet CPAP as
ﬁrst-line prehospital treatment of presumed severe acute
pulmonary edema. In prehospital treatment of 62 patients
with ACPE, CPAP was added to standard medical treat-
ment, while in another 59 patients CPAP was used as sole
therapy. Helmet CPAP was feasible in all cases. No
patient required prehospital intubation. In both groups,
CPAP signiﬁcantly improved oxygenation, reduced RR,
and improved hemodynamics, with more pronounced
decrease in blood pressure in the group with combined
medical treatment. In the two cohorts, four and ﬁve
patients were, respectively, intubated in the Emergency
Department, and 11 and 9 died.
Bellani et al. [8] described and tested a modiﬁed
Boussignac system for noninvasive CPAP, aimed at
reducing the decrease in FiO2 with higher inspiratory
peak ﬂow rates. The authors modiﬁed a Boussignac cir-
cuit by inserting a T-piece between the Boussignac valve
and the face mask. The T-piece was connected to a res-
ervoir balloon receiving oxygen from an independent
source. The system was tested in a bench study, consisting
of ﬁve steps, with increasing inspiratory peak ﬂow rate
(Vinsp). Three levels of positive end-expiratory pressure
(PEEP) were tested: 7, 10, and 13 cmH2O, with the fol-
lowing devices: Boussignac, Boussignac with reservoir
but without supplementary oxygen, and Boussignac with
reservoir and 10 (SUPER-Boussignac10) and 30 l/min
(SUPER-Boussignac30) supplementary oxygen. In each
step, FiO2,V T, and airway pressure were measured. FiO2
increased with PEEP and decreased with increasing Vinsp
for all the systems. However, FiO2 increased with
SUPER-Boussignac10 (7–10%) and with SUPER-Bous-
signac30 (10–30%). Moreover, in the latter case, for
Vinsp values up to 60 l/min, FiO2 became independent of
Vinsp. The SUPER-Boussignac allowed also smaller drop
in airway pressure during inspiration and higher tidal
volumes. It was concluded that SUPER-Boussignac rep-
resents a simple way to signiﬁcantly improve the
performance of the Boussignac device.
Few studies have evaluated mechanisms of respiratory
failure in the very early phases of acute exacerbation of
chronic obstructive pulmonary disease (COPD). Purro
et al. [9] measured respiratory mechanics in patients with
early COPD exacerbation treated with NIV or with
medical therapy only, and compared data with those
obtained in stable, long-term mechanically ventilated,
COPD patients [intermittent positive-pressure ventilation
(IPPV)]. Patients treated with NIV and IPPV had rapid
shallow breathing associated with higher drive to breath
and higher diaphragmatic tension-time index than patients
managed with medical therapy only, suggesting that,
during the early phases of acute exacerbation of COPD,
there is a load–capacity imbalance of respiratory muscles
similar to that observed in stable COPD. Only dynamic,
intrinsic PEEP was different between NIV and IPPV
patients, with highest values observed in the latter group.
Patients with chronic respiratory insufﬁciency often
suffer from sleep disruption, secondary to impaired ven-
tilation and gas exchange during sleep. In these patients,
Ambrogio et al. [10] evaluated whether a new ventilatory
mode, averaged volume-assured pressure support (AV-
APS), and lateral position were associated with better
sleep efﬁciency than conventional pressure support (PS)
and supine position during NIV. Sleep efﬁciency was
comparable with AVAPS and PS, in spite of greater
minute ventilation with AVAPS, and was worse in supine
than lateral position. Minute ventilation was not inﬂu-
enced by body position, and decreased progressively from
wakefulness through various stages of sleep.
Adaptation to the interface plays an important role in
NIV efﬁcacy. In a randomized, controlled trial, Cuvelier
et al. [11] compared the clinical efﬁcacy of cephalic and
oronasal masks in patients with acute hypercapnic respi-
ratory failure. Respiratory acidosis, encephalopathy and
respiratory distress scores, and respiratory rate improved
similarly with both masks, indicating comparable clinical
efﬁcacy. Tolerance to oronasal mask gradually improved,
and it was better than cephalic mask at 24 and 48 h.
Iron lung ventilation (ILV) is an alternative form of
noninvasive ventilatory assistance for COPD patients
with acute exacerbation. In these patients, Corrado et al.
[12] compared the efﬁcacy of ILV versus conventional
NIV delivered through face mask. When used as ﬁrst line,
ILV had a success rate greater than NIV (87% versus
68%); after the shift of the techniques, however, need for
endotracheal intubation and mortality were similar.
Sequential use of both techniques signiﬁcantly increased
the total success rate and avoided endotracheal intubation
in a high percentage of patients.
NIV is increasingly used outside the ICU. Cabrini
et al. [13] reported data about NIV use outside the ICU
managed by a medical emergency team (MET) in an
experienced center. Success rate was high (78%), with
large variations among different diseases. Complications
were few and without clinical consequences. MET
workload was high, with an average of three patients
simultaneously treated. Demoule [14], in the related edi-
torial, highlighted that application of NIV outside the ICU
under the supervision of an MET is an interesting
approach that needs, however, high training and expertise
and is not easy to apply in every hospital.
Patient–ventilator asynchrony during NIV for ARF
has been assessed in a multicenter study by Vignaux et al.
[15]. Airway pressure, ﬂow, and surface diaphragmatic
electromyography were recorded continuously for
30 min. Asynchrony events and the asynchrony index
569(AI) were determined from visual inspection of the
recordings and clinical observation in 60 patients, 55% of
whom were hypercapnic. Autotriggering was present in 8
(13%) patients, double triggering in 9 (15%), ineffective
breaths in 8 (13%), premature cycling in 7 (12%), and late
cycling in 14 (23%). AI [10%, indicating severe asyn-
chrony, was present in 26 patients (43%), whose median
(25–75% interquartile range, IQR) AI was 26% (15–
54%). A signiﬁcant correlation was found between the
magnitude of leaks and the number of ineffective breaths
and severity of delayed cycling. Multivariate analysis
indicated that the level of pressure support and the mag-
nitude of leaks were weakly, although signiﬁcantly,
associated with AI [10%. Patient comfort scale was
higher with AI \10%, suggesting that patient–ventilator
asynchrony is common in patients receiving NIV for
ARF, and leaks play a major role in generating patient–
ventilator asynchrony and discomfort. Because no clear
recommendation exists concerning humidiﬁcation during
NIV and high-ﬂow CPAP, and few hygrometric data are
available, Lellouche et al. [16] measured hygrometry
during NIV delivered to healthy subjects with different
humidiﬁcation strategies of: heated humidiﬁer (HH), heat
and moisture exchanger (HME), or no humidiﬁcation
(NoH). For each strategy, a turbine and an ICU ventilator
were used with different FiO2 settings, with and without
leaks. During CPAP, two different HH and NoH were
tested. Inspired gases hygrometry was measured, and
comfort was assessed. On a bench, they also assessed the
impact of ambient air temperature, ventilator temperature,
and minute ventilation on HH performances (with NIV
settings). During NIV, with NoH, gas humidity was very
low when an ICU ventilator was used (5 mgH2O/l), but
equivalent to ambient air hygrometry with a turbine
ventilator at minimal FiO2 (13 mgH2O/l). HME and HH
had comparable performance (25–30 mgH2O/l), but
HME’s effectiveness was reduced with leaks (15 mgH2O/
l). HH performances were reduced by elevated ambient
air and ventilator output temperatures. During CPAP, dry
gases (5 mgH2O/l) were less tolerated than humidiﬁed
gases. Gases humidiﬁed at 15 or 30 mgH2O/l were
equally tolerated. It was concluded that HH and HME
provide gas with the highest water content. Comfort data
suggested that levels above 15 mgH2O/l are well toler-
ated. In favorable conditions, HH and HMEs are capable
of providing such values, even in the presence of leaks.
This article has an editorial comment [17]. No recom-
mendation exists concerning humidiﬁcation during
oxygen therapy in ICU. Chanques et al. [18] performed a
clinical and bench study to assess discomfort and
hygrometry with bubble (BH) and HH during high-ﬂow
oxygen therapy (HFOT). Mouth and throat dryness were
lower, whereas absolute humidity was greater, with HH
than BH, suggesting that HH may decrease dryness
symptoms through increased humidity delivered to the
patient. Ricard et al. [17] remarked that discomfort during
oxygen therapy showed wide interpatient variability and
its relief was incomplete with both devices, recommend-
ing that individual assessment of discomfort should be
performed before starting humidiﬁcation.
Ventilator performances and ventilatory modes
In a bench study [19], 13 commercially available, new-
generation, ICU ventilators were compared in terms of
trigger function, pressurization capacity during pressure-
support ventilation (PSV), accuracy of pressure measure-
ments, and expiratory resistance. Four turbine-based
ventilatorsandnineconventionalservo-valvecompressed-
gas ventilators were tested using a two-compartment lung
model. Three levels of effort were simulated. Each venti-
lator was evaluated at four PSV levels (5, 10, 15, and
20 cm H2O), with and without PEEP (5 cmH2O). Trigger
function was assessed as the time from effort onset to
detectable pressurization. Pressurization capacity was
evaluated using the airway pressure–time product, com-
puted as the net area under the pressure–time curve over
the ﬁrst 0.3 s after inspiratory effort onset. Expiratory
resistance was evaluated by measuring trapped volume in
controlled ventilation. Signiﬁcant differences were found
across the ventilators, with a range of triggering delays
from 42 to 88 ms for all conditions averaged (P\0.001).
Under difﬁcult conditions, the triggering delay was longer
than 100 ms and the pressurization was poor for ﬁve
ventilators at PSV5 and three at PSV10, suggesting an
inability to unload patient’s effort. On average, turbine-
based ventilators performed better than conventional
ventilators, which showed no improvement compared with
a bench comparison in 2000. It was concluded that tech-
nical performance of trigger function, pressurization
capacity, and expiratory resistance differs considerably
across new-generation ICU ventilators. ICU ventilators
seem to have reached a technical ceiling in recent years,
and some ventilators still perform inadequately.
Modern ICU ventilators offer sophisticated monitoring
and new modes. Their user-friendliness has been poorly
evaluated. Vignaux et al. [20] evaluated the time needed
by ten physicians experienced in mechanical ventilation,
but without prior knowledge of tested ventilators, to
perform speciﬁc tasks. All physicians’ times were sig-
niﬁcantly higher than a reference time (by trained
physiotherapist familiar with the devices). Heterogeneity
existed among machines, but no ventilator was clearly the
best. Task failure ([180 s) was 16%, mainly mode and
parameter recognition, starting pressure support, and
ﬁnding NIV mode. Conclusion was that user-friendliness
of ventilators should be improved by promoting closer
ties between end-users and manufacturers. Richard et al.
[21] underlined that, apart from ventilators’ ergonomics,
adequate competency is a prerequisite for independently
manipulating the ventilator.
570Respiratory pressure–volume (PV) curve is now
available on several ventilators. Piacentini et al. [22]
compared PV curves obtained from a ventilator with a
reference technique (CPAP method) in patients with ALI-
ARDS. Lower and upper inﬂection points, and point of
deﬂation maximum curvature showed good correlation
between methods, suggesting that the ventilator tool for
PV curve tracing is a valid alternative at the bedside.
Nonconventional ARF management, outcome,
and positioning
Weber-Carstens et al. [23] evaluated spontaneous breath-
ing using pumpless extracorporeal lung assist (p-ECLA) in
patients with late ARDS and hypercapnia. The median
reduction in PaCO2 was 50% following institution of
p-ECLA. Extracorporeal CO2 removal enabled signiﬁcant
reduction in tidal volumes (to below 4 ml/kg predicted
body weight) and inspiratory plateau pressures. The pro-
portion of assisted spontaneous breathing increased within
24 h of instituting p-ECLA, suggesting that elimination of
CO2 by p-ECLA therapy allowed reduction of ventilator-
induced shear stress throughventilation with tidal volumes
below 4 ml/kg predicted body weight.
Brogan et al. [24] evaluated, in a retrospective man-
ner, clinical and treatment factors for patients recorded in
the Extracorporeal Life Support Organization (ELSO)
registry and survival of adult extracorporeal membrane
oxygenation (ECMO) respiratory failure patients from
1986 to 2006. Data were analyzed separately for the entire
time period and the most recent years (2002–2006). Of
1,473 patients, 50% survived to discharge. Median age
was 34 years. Most patients (78%) were supported with
venovenous ECMO. In a multivariate logistic regression
model, pre-ECMO factors including increasing age,
decreased weight, days on mechanical ventilation before
ECMO, arterial blood pH B7.18, and Hispanic and Asian
race compared with White race were associated with
increased odds of death. For the most recent years
(n = 600), age and PaCO2 C70 compared with PaCO2
B44 were also associated with increased odds of death.
The two diagnostic categories ARF and asthma compared
with ARDS were associated with decreased odds of
mortality, as was venovenous compared with venoarterial
mode. Cardiopulmonary resuscitation (CPR) and com-
plications while on ECMO including circuit rupture,
central nervous system infarction or hemorrhage, gastro-
intestinal or pulmonary hemorrhage, and arterial blood pH
\7.2 or [7.6 were associated with increased odds of
death. It was concluded that survival among this cohort of
adults with severe respiratory failure supported with
ECMO was 50%. Advanced patient age, increased pre-
ECMO ventilation duration, diagnosis category, and
complications while on ECMO were associated with
mortality.
Sleep disruption is well recognized in the ICU. Poor
sleep quality continues following discharge from hospital
in several patients and becomes a chronic disorder in
some. Lee et al. [25] aimed to describe the etiology of
chronic sleep complaints in survivors of ARDS. Seven
ARDS survivors with no previous sleep complaints who
reported difﬁculty sleeping 6 months or more following
discharge from hospital were evaluated. Sleep quality was
assessed subjectively with a sleep history and the
Insomnia Severity Index, and objectively with polysom-
nography. Daytime sleepiness was assessed with the
Epworth Sleepiness Scale. A chronic sleep disorder was
identiﬁed in each patient who reported difﬁculty sleeping.
The primary sleep disorder was chronic conditioned
insomnia (ﬁve patients), parasomnia (one patient), and
obstructive sleep apnea (one patient). In addition, four
patients had periodic leg movements, which was of
uncertain clinical signiﬁcance. It was concluded that
survivors of ARDS are at risk to develop chronic sleep
disorders, and that further research is required to deter-
mine the prevalence and natural history of chronic sleep
disorders in this patient population.
An epidemiological study by Metnitz et al. [26] eval-
uated the current practice of mechanical ventilation in the
ICU and the characteristics and outcomes of ventilated
patients. The investigation was designed as a preplanned
substudy of a multicenter, multinational cohort study of
the SAPS 3 project. A total of 13,322 patients admitted to
299 intensive care units (ICUs) from 35 countries were
analyzed. More than half of the patients (53%) were
mechanically ventilated at ICU admission. FiO2,V T, and
PEEP used during invasive MV were on average 50%,
8 mL/kg actual body weight, and 5 cmH2O, respectively.
As much as 17.3% of patients under invasive MV were
ventilated with zero PEEP (ZEEP). These patients exhib-
ited signiﬁcantly increased risk-adjusted hospital
mortality, compared with patients ventilated with higher
PEEP (1.12, 95% CI: 1.05–1.18). Noninvasive ventilation
was used in 4.2% of all patients and was associated with
improved risk-adjusted outcome (OR 0.79, 95% CI: 0.69–
0.90). The authors concluded that mechanical ventilation
is one of the most common interventions employed in the
intensive care unit (more than 50% of patients were under
mechanical ventilation). The use of MV is variable, with
30% of patients having ALI being ventilated with tidal
volumes[8 ml/kg actual body weight. Invasive MV with
ZEEP was associated with worse outcome, even after
controlling for severity of disease. Since this study did not
document indications for MV, the association between
MV settings and outcome must be viewed with caution.
This article has an editorial comment [27].
Linko et al. [28] analyzed ARF incidence, treatment,
and mortality in Finnish ICUs. Ventilatory support[6h
wasneededin39%ofadmittedpatients.IncidenceofARF,
ALI,and ARDSwas 149.5,10.6,and5.0/100,000peryear,
with ARF 90-day mortality of 31%. Assisted ventilatory
571modes were preferred (81%). Median tidal volume/pre-
dicted body weight was 8.7 ml/kg, and plateau pressure
was 19 cmH2O. Thus, while incidence of ARF requiring
ventilatory support is higher, incidence of ALI and ARDS
is lower in Finland than in other countries. Tidal volumes
were higher than recommended for lung protection, but
airway pressures were limited in the majority of patients.
Estenssoro [29] underlined differences and similarities
between this study and others previously published.
Protti et al. [30] wished to clarify whether the gas
exchange response to prone position is associated with
lung recruitability in mechanically ventilated patients with
acute respiratory failure. In 32 patients, gas exchange
response to prone position was investigated as a function
of lung recruitability, measured by computed tomography
in supine position. No relationship was found between
increased oxygenation in prone position and lung recru-
itability. In contrast, the decrease of PaCO2 was related
with lung recruitability (R
2 = 0.19; P = 0.01). Patients
who decreased their PaCO2 more than the median value
(-0.9 mmHg) had greater lung recruitability (19 ± 16%
versus 8 ± 6%; P = 0.02), higher baseline PaCO2
(48 ± 8 versus 41 ± 11 mmHg; P = 0.07), heavier lungs
(1,968 ± 829 versus 1,521 ± 342 g; P = 0.06), and more
nonaerated tissue (1,009 ± 704 versus 536 ± 188 g;
P = 0.02) than those who did not. It was concluded that,
during prone position, changes in PaCO2, but not in oxy-
genation, are associated with lung recruitability, which in
turn is associated with severity of lung injury.
Keulenaer et al. [31] described what is deﬁned as
normal intra-abdominal pressure (IAP) and how body
positioning, body mass index (BMI), and positive end-
expiratory pressure (PEEP) affect IAP monitoring. The
underlying notion is that the abdomen truly behaves as a
hydraulic system. A review of different databases was
made. The deﬁnitions of normal IAP in the general patient
population and morbidly obese patients were reviewed.
Subsequently, factors that affect the accuracy of IAP
monitoring, i.e., body position (head-of-bed elevation,
lateral decubitus and prone position) and PEEP, were
explored. It was concluded that the abdomen behaves as a
hydraulic system with normal IAP of about 5–7 mmHg,
and with higher baseline levels in morbidly obese patients
of about 9–14 mmHg. Measuring IAP via the bladder in
the supine position is still the accepted standard method,
but in patients in the semirecumbent position (head of bed
elevated to 30 and 45), the IAP on average is 4 and
9 mmHg, respectively, higher. Small increases in IAP in
stable patients without intra abdominal hypertension
(IAH), turned prone, have no detrimental effects.
Heart–lung interactions and biomarkers
Feihl and Broccard [32, 33] provide a Guytonian analysis
of the effects of PEEP on cardiac output, and terminate
the review with some remarks on the potential of positive
pressure breathing to induce acute cor pulmonale, and on
the cardiovascular mechanisms that underlie failure to
wean a patient from the ventilator. These two articles
must be mandatory to read and understand for every in-
training intensivist and also for board-certiﬁed specialists
in this ﬁeld, providing in-depth, state-of-the-art descrip-
tion of cardiorespiratory interactions. In the ﬁrst part of
the review, the authors provide a few, clear, simple
physiological concepts covering the cardiorespiratory
interactions to explain the theoretical framework. In the
second part of the review, the authors apply these con-
cepts to clinical situations and thus put this theoretical
framework of cardiorespiratory interactions into practical
use. In particular, they describe mechanisms underlying
Kussmaul’s sign and pulsus paradoxus. They review the
literature on the use of respiratory variations of blood
pressure to evaluate volume status (for instance, by
investigating with ultrasonography how the geometry of
great veins ﬂuctuates with respiration).
Studies have shown that biomarkers in body ﬂuids of
patients with ALI and ARDS may provide insight into the
pathogenesis and prognosis of these entities. Calfee et al.
[34] aimed to determine whether levels of soluble inter-
cellular adhesion molecule-1 (sICAM-1), a marker of
alveolar epithelial and endothelial injury, differ in patients
with hydrostatic pulmonary edema and ALI and are
associated with clinical outcomes. Measurement of
sICAM-1 levels were performed in: (1) plasma and edema
ﬂuid from 67 patients with either hydrostatic pulmonary
edema or ALI enrolled in an observational, prospective
single-center study, and (2) in plasma from 778 patients
with ALI enrolled in a large multicenter randomized
controlled trial of ventilator strategy. In the single-center
study, levels of sICAM-1 were signiﬁcantly higher in both
edema ﬂuid and plasma (median 938 and 545 ng/ml,
respectively) from ALI compared with hydrostatic edema
patients (median 384 and 177 ng/ml; P\0.03 for both
comparisons). In the multicenter study, higher plasma
sICAM-1 levels were associated with poor clinical out-
comes. Subjects with ALI whose plasma sICAM-1 levels
increased over the ﬁrst 3 days of the study had higher risk
of death, after adjusting for other important predictors of
outcome (odds ratio 1.48; 95% CI 1.03–2.12, P = 0.03).
The authors concluded that higher plasma sICAM-1 lev-
els and increasing sICAM-1 levels over time are
associated with poor clinical outcomes in ALI. Mea-
surement of sICAM-1 levels may be useful for identifying
patients at highest risk of poor outcomes from ALI.
Heme oxygenase-1 (HO-1) acts in cytoprotection
against acute lung injury, and the polymorphic (GT)n
repeat in the HO-1 gene (HMOX1) promoter regulates
HMOX1 expression. Sheu et al. [35] investigated the
associations of HMOX1 polymorphisms with acute
respiratory distress syndrome (ARDS) risk and plasma
HO-1 levels in an unmatched, nested case–control study.
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admission were prospectively enrolled. Cases were 437
Caucasians who developed ARDS, and controls were
1,014 Caucasians who did not. The (GT)n polymorphism
and three tagging single-nucleotide polymorphisms
(tSNPs) were genotyped in 1,451 patients, and plasma
HO-1 levels were measured in 106 ARDS patients. The
(GT)n repeats were clustered into: S-allele (\24 repeats),
M-allele (24–30 repeats), and L-allele (C31 repeats). It
was found that longer (GT)n repeats were associated with
reduced ARDS risk (Ptrend = 0.004 for both alleles and
genotypes), but no individual tSNP was associated with
ARDS risk. HMOX1 haplotypes were signiﬁcantly asso-
ciated with ARDS risk (global test, P = 0.016), and the
haplotype S-TAG was associated with increased ARDS
risk (odds ratio, 1.75; 95% CI: 1.15–2.68, P = 0.010).
Intermediate-phenotype analysis showed that longer
(GT)n repeats were associated with higher plasma HO-1
levels (Ptrend = 0.019 for alleles and 0.027 for geno-
types). It was concluded that longer (GT)n repeats in the
HMOX1 promoter are associated with higher plasma
HO-1 levels and reduced ARDS risk. The common hap-
lotype S-TAG was associated with increased ARDS risk.
The results suggest that HMOX1 variation may modulate
ARDS risk through promoter microsatellite polymor-
phism. This article has an editorial comment [36].
Preclinical studies suggest that 3-hydroxy-3-methyl-
glutaryl-coenzyme A (HMG-CoA) reductase inhibitors
(statins) may attenuate organ dysfunction. In a retro-
spective study [37], it was evaluated whether statins are
associated with attenuation of lung injury and prevention
of associated organ failure in patients with ALI/ARDS.
From a database of patients with ALI/ARDS, the presence
and timing of statin administration were determined.
Main outcome measures were development and progres-
sion of pulmonary and nonpulmonary organ failure as
assessed by changes in PaO2/FiO2 ratio and Sequential
Organ Failure Assessment (SOFA) score between days 1
and 7 after the onset of ALI/ARDS. Secondary outcomes
included ventilator-free days, ICU and hospital mortality,
and lengths of ICU and hospital stay. From 178 patients
with ALI/ARDS, 45 (25%) received statin therapy. From
day 1 to day 7, the statin group showed less improvement
in their PaO2/FiO2 ratio (27 versus 55, P = 0.042).
Ventilator-free days (median 21 versus 16 days,
P = 0.158), development or progression of organ failures
(median DSOFA: 1 versus 2, P = 0.275), ICU mortality
(20% versus 23%, P = 0.643), and hospital mortality
(27% versus 37%, P = 0.207) were not signiﬁcantly
different in the statin and nonstatin groups. After adjust-
ment for baseline characteristics and propensity for statin
administration, there were no differences in ICU or hos-
pital lengths of stay. It was concluded that statin use was
not associated with improved outcome in patients with
ALI/ARDS, and the authors were unable to ﬁnd evidence
for protection against pulmonary or nonpulmonary organ
dysfunction. This article was followed by a letter to the
editor and its rebuttal [38].
Respiratory monitoring
Early detection of ALI may be considered essential for
implementation of adequate therapeutic measures. Com-
puterized syndrome surveillance systems may be a useful
tool in achieving improved early detection. ALI electronic
alert (ALI ‘‘sniffer’’) was developed and validated in a
study including 3,795 critically ill patients in the USA
[39]. As compared with routine clinical bedside assess-
ment achieving diagnosis of ALI in only 27% of
detections, the ALI sniffer improved recognition of ALI
signiﬁcantly. Demonstrated sensitivity of 96% and spec-
iﬁcity of 98% by applying the ALI sniffer suggest a role
for this approach in daily practice.
Electrical impedance tomography (EIT) is a new tool
for bedside monitoring of lung volumes. Bikker et al. [40]
evaluated the relationship between measured end-expira-
tory lung volume (EELV) and EELV calculated by EIT
recorded at the basal part of the lung with different PEEP.
The tidal impedance variation to tidal volume ratio varied
with PEEP and between patients. A low correlation and
moderate agreement between methods were observed,
suggesting that EIT is inaccurate for calculation of EELV
when impedance is measured at only one thoracic level
just above the diaphragm during PEEP trial.
EITintherespiratoryﬁeldis,however,developingfast,
and another couple of papers have focused on this tech-
nique. Costa et al. [41] made comparisons between EIT,
using a novel algorithm, and computed tomography (CT)
for detecting alveolar recruitment. They also went one step
further and proposed a measure of lung hyperdistension by
combining EIT ﬁndings of aeration and regional lung
mechanics. Zhao et al. [42] developed and tested an indi-
cator of inhomogeneous ventilation (GI index). They
compared 40 patients with lung injury requiring ventilator
treatment with 10 patients who were lung-healthy and
ventilated during anesthesia. The conclusion was that the
GI index is able to detect and quantify gas distribution
inhomogeneity, providing a single number that may facil-
itate trend analysis. This is reminiscent of the various
indices that were developed during the 1950s and 1960s
from multiple breath nitrogen washout techniques. The
papers on alveolar recruitment and ventilation distribution
by Costa and Zhao with coworkers bring us to an invited
review by Glenny [43] on ‘‘Determinants of regional ven-
tilation of blood ﬂow in the lungs.’’ Glenny covers the
different causes of ventilation and perfusion inhomogene-
ity. It should be remembered that this excellent review is
writtenbyascientistwhodaredtoquestiontheinﬂuenceon
theventilationandperfusiondistributionssolelybygravity,
and he has successfully demonstrated additional and
sometimes more important causes of this inhomogeneity.
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issue—stress and strain—asking ‘‘Is there an optimal
breath pattern to minimize stress and strain during
mechanical ventilation?’’. For that purpose they deﬁned
an index to quantify the impact of positive pressure
ventilation on the lung [the Stress–Strain Index (SSI)] and
tested it in a mathematical model. They found that, if the
ventilator is adjusted according to this index, the resulting
tidal volume would be lower (0.25 l) and the respiratory
rate higher (39 breaths/min) than according to the
ARDSNet trial (tidal volume 0.42 l and 17 breaths/min).
New modes
Some papers deal with a rather recent technique on
guiding the ventilator: neurally adjusted ventilatory assist
(NAVA). This technique demands that the diaphragm
electromyograph (EMG) be measured with an acceptable
signal-to-noise ratio. Barwing et al. [45] tested the efﬁ-
ciency of positioning the esophageal EMG catheter
according to the following criteria: stable EMG signal,
electrical activity mainly in central leads of the catheter,
and absence of the p-wave coming from the electrocar-
diogram (ECG) (OPT technique). Using these criteria all
26 patients that were studied could be ventilated using
NAVA. A previously used technique which takes into
account the distance from nose to earlobe to xyphoid
process was inferior to the OPT technique.
NAVA and proportional-assist ventilation with load-
adjustable gain factors (PAV?) were evaluated in two
other papers [46, 47]. Brander et al. [46] assessed the
degree of lung protection with NAVA as compared with
conventional volume-controlled ventilation in a rabbit
model of ALI. Tidal volume (VT) was lower and respi-
ratory rate was higher during NAVA. Both oxygenation
and arterial CO2 were higher with NAVA. Variables
assessing ventilator-induced lung injury (VILI) and non-
pulmonary organ dysfunction were similarly decreased
with both strategies, compared with high-VT (15 ml/kg)
ventilation. The authors concluded that allowing animals
with lung injury to choose their respiratory pattern with
NAVA is as effective as conventional, volume-controlled
ventilation in preventing VILI, in attenuating systemic
and extrapulmonary organ inﬂammation, and in preserv-
ing cardiac and kidney function. Brochard, in the related
editorial [48], explained the potential relevance of letting
patients freely choose their respiratory pattern, underlying
that the degree of freedom and the optimal NAVA setting
remain matters of research.
Xirouchaki et al. [47] evaluated PAV? user-friendli-
ness, by comparing the number of changes in ventilator
settings and in dosage of analgesics, sedatives, and
vasoactive drugs with PAV? or pressure support (PS).
Changes in ventilator settings and in the dose of sedatives
were less with PAV? than with PS. Dyssynchrony as a
cause of modiﬁcation of ventilator settings was more
common with PS (41% versus 3%). Conclusion was that
PAV? is a user-friendly mode, associated with fewer
changes in ventilator settings and in sedative dosing
compared with PS.
Endotracheal intubation-related problems
Although touching a quite different ﬁeld of intensive care
medicine, a review by Ochoa et al. [49] is very interesting
and possibly a bit nearer to the daily practice of the in-
tensivist. The investigators evaluated the diagnostic
accuracy of the so-called cuff-leak test for diagnosis of
upper airway obstruction secondary to laryngeal edema
and for intubation secondary to upper airway obstruction.
They selected nine comparable studies in the literature
with signiﬁcant heterogeneity, as expected. Nonetheless,
sensitivity and speciﬁcity of the test to demonstrate
obstruction were quite impressive; the diagnostic odds
ratio was signiﬁcant for both questions. Hence, the
authors concluded that, when it is positive (i.e., no
‘‘leak’’), this test should alert the clinician to a high risk of
upper airway obstruction. On the other hand, the detection
of a leak (i.e., negative test) has only low predictive value
and does not rule out the occurrence of obstruction or the
need for re-intubation. This is an important paper espe-
cially for units with a high rate of patients with complex
neck and/or larynx surgery. A similar problem, i.e., pre-
vention of extubation failure, was the topic of another
literature review by McCaffrey et al. [50]. The speciﬁc
question addressed was whether corticosteroids reduce
the rate of extubation failure in intensive care patients.
Fourteen randomized trials were selected and demon-
strated a reduction in reintubation with use of
corticosteroids by roughly 50%. Importantly, this
improvement was shown in all age groups of patients. As
extubation failure is associated with signiﬁcant morbidity
and mortality, clinicians should consider use of cortico-
steroids in patients at high risk of extubation failure,
similar to in the aforementioned paper.
The extubation outcome is importantly conditioned by
cough strength. Beuret et al. [51] evaluated the role of
peak cough expiratory ﬂow (PCEF) as a predictor of
extubation outcome in patients having successfully passed
the spontaneous breathing trial. PCEF was signiﬁcantly
associated with extubation failure. The inability to cough
at order or PCEF B35 l/min predicted extubation failure
with sensitivity of 79% and speciﬁcity of 71%.
Pediatrics
Problems related to sedative and analgesic drugs are
common in both adult and children receiving intensive
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sedation such as protocol-based prescription, daily drug
‘‘holidays,’’ and the use of pain and sedation scores are as
relevant in children as in adults. Inoue et al. [52] reported
a retrospective cohort study to evaluate whether use of
early ketorolac to manage pain increased the risk of renal
dysfunction in children undergoing low-risk cardiac sur-
gery. No differences were seen between the two groups in
plasma creatinine. The use of ketorolac was associated
with an opioid-sparing effect, although no clinically sig-
niﬁcant difference in length of intensive care stay was
evident. The use of scoring systems is well established for
titration of analgesia and sedation. Some children exhibit
withdrawal symptoms after receiving prolonged or high-
dose ‘‘sedative’’ drugs in ICU. However, the occurrence
of withdrawal is likely to be underreported, especially if it
is not systematically sought. Ista et al. [53] reported a
careful observation of a large panel of signs and symp-
toms including agitation, motor disturbances diarrhea,
fever, anxiety, sleep disturbance, and hypertension on 76
children who had received intravenous midazolam and/or
opioids in a pediatric ICU (PICU) for[5 days. From this
rich resource, 15 discriminatory symptoms were selected
by multidimensional scaling for inclusion in a resulting
instrument, the Sophia Observation Withdrawal Symptom
(SOS) scale. Routine use of withdrawal scores is
increasingly recommended for children receiving ‘‘seda-
tion’’ for over 72 h [54]. It is well documented that adult
[55] and child [56] survivors of critical illness may
exhibit symptoms of depression or other psychological
disturbances. Colville et al. [57] focus on a surprisingly
positive aspect of postcritical outcome in children,
reporting that ‘‘posttraumatic growth,’’ a phenomenon
whereby a traumatized person may ultimately come to
function at a higher level than before, is detectable in
survivors of pediatric critical illness, a ﬁnding which has
been detected in some other ‘‘stress and trauma’’ survi-
vors [58].
There is currently a high level of interest in both adult
and pediatric critical care in the accurate reporting of
renal dysfunction. To this end, the risk of renal failure,
injury to kidney, failure of kidney function, loss of kidney
function and end-stage renal failure (RIFLE) score [59],
and its pediatric modiﬁcations such as pRIFLE [60], are
useful tools. Palmieri et al. [61] used the modiﬁed pedi-
atric RIFLE criteria to characterize severity of acute
kidney injury (AKI) in a cohort of 123 children with
burns, in whom they found an incidence of AKI of 45.5%.
Presence of sepsis and septic shock were independent risk
factors for the Failure class of AKI. Renal replacement
therapy (RRT) in infants and children can be technically
very challenging. In the April issue of the Journal,
Maclaren and Butt present a succinct review of the sub-
ject of pediatric RRT and welcome the discipline and
potential for systematic study enabled by the founding of
the Pediatric Renal Replacement Therapy Registry [62].
In the same issue of the Journal, Zappitelli et al. report the
results of a prospective observational study on the nutrient
balance of critically ill children receiving continuous
venovenous hemodialysis (CVVHD), speciﬁcally dialysis
clearance, and quantify amino acid, trace metal, and
folate losses, and the relationship of these losses to daily
nutrient intake. They conclude that signiﬁcant amino acid,
folate, and some trace metal losses occur by CVHHD, and
that these losses may have a signiﬁcant impact on nutri-
tion provision.
Critical status at all ages is virtually synonymous with
mechanical ventilation. Respiratory support in the new-
born, especially the premature neonate, is particularly
challenging. For this reason, much of our understanding of
neonatal lung disease and its management relies on animal
studies. Pillow et al. [63] reported a study in the Sep-
tember issue of the Journal in which they studied the
inﬂammatory potential of hyperoxia and low inspired gas
humidity in near-term lambs. Compared with 100% oxy-
gen, cold dry gas had a less marked effect on interleukin
(IL)-1, IL-8, and cytokine messenger RNA (mRNA)
expression, emphasizing the toxic potential of relatively
short (3 h) exposure to high FiO2 in the immature lung.
Two papers published in 2009 addressed the challenges of
respiratory monitoring in neonates. Fisher et al. [64]
investigated the accuracy of a commercially available
Y-piece ﬂow-sensor-based device [65] to measure tidal
volume in preterm neonates receiving nasopharyngeal
CPAP. Some measurements were possible, but the inves-
tigators found that the %leak often exceeded the
measurement range of the device, and that overall reliable
measurement was not possible using the system tested. In
the same issue of the Journal, Lopez [66] reported a
clinical study comparing the use of side-stream end-tidal
(EtCO2) and transcutaneous carbon dioxide (TcPCO2)
measurement against a reference standard of mixed
venous blood (PvCO2) in ventilated preterm infants. Good
correlation was observed between TcPCO2 and PvCO2,
but not between EtCO2 and PvCO2 or between EtCO2 and
TcPCO2. However, EtCO2 accurately identiﬁed clinically
relevant, high and low PvCO2 cutoffs and could therefore
be used as a monitoring device to maintain PvCO2 within
safety margins. The importance of performing studies in
speciﬁc young populations was highlighted by the reports
of Riedel et al. and van Veenendaal et al. [67, 68]. Both
groups used electrical impedance technology-based mea-
surement techniques. Riedel et al. determined that there
were distinct differences between ventilation distribution
between preterm and term infants detectable by EIT but
not by multiple breath washout (MBW) technique. This is
an important ﬁnding, as previous studies in neonates based
on MBW measurements may need to be reassessed. van
Veenendaal et al. report a simple ﬁnding, again based on
lung volume studies with EIT, that lung volume decreases
when episodes of closed endotracheal suction take place in
infants receiving high-frequency open-lung ventilation for
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possibility of noninvasive assessment of lung volume in
clinical situations previous regarded as too difﬁcult to
study with alternative, invasive techniques. Accurate
measurement during ventilation in older children can also
be challenging for the clinician. Bikker et al. [69] reported
on the measurement of EELV in intubated children with-
out interruption of mechanical ventilation with a ventilator
incorporating a built-in nitrogen washout/wash-in EELV
capability [70] previously validated in adults. The authors
conclude that the nitrogen washout EELV device could
measure EELV with good precision in children and that
the device can readily be used in mechanically ventilated
pediatric patients without need for additional tracer gas or
interruption of mechanical ventilation.
Differing modes of ventilatory support continue to
compete for places in the pediatric intensive care league
tables. Khemani et al. [71] reported a large single-center
study of ventilatory strategies in a cohort of 398 mechan-
ically ventilated children with PaO2/FiO2 ratio\300. All
were ventilated using pressure control ventilation, with
85%achieving tidalvolume less than 10 ml/kg.From their
results, the investigators reportedthatthey could notdetect
any difference in mortality between tidal volumes of 6 and
10 ml/kg and importantly that higher tidal volumes within
this range were associated with fewer ‘‘ventilator-free
days.’’ Two papers in 2009 reported on use of NIV in
critically ill children. Piastra et al. [72] reported their early
experience of use of NIV in 23 immunocompromised
children with ARDS. Thirteen (55%) avoided intubation.
Whilst use of NIV is stated to have been well tolerated and
may have some theoretical advantages over invasive ven-
tilation in this particularly vulnerable group, a carefully
designed randomized controlled trial is needed to establish
the role of NIV in the management of pediatric acute
respiratory failure. Paiva et al. reported a study in which
they observed that 21/50 (42%) children receiving long-
term NIV developed nocturnal hypercapnia. They per-
formed a validation of combined SpO2 and PtcCO2 against
capillary arterialized blood gas samples and recommended
that such monitors be used in long-term ventilated chil-
dren. Finally, Stucki et al. [73] reported on use of NIV to
support six post-cardiac-surgery children who developed
respiratory failure after extubation. The study demon-
strated the occurrence of a consistent improvement in the
breathing pattern of infants submitted to NIV, as docu-
mented by reduction of dyspnea score. Analysis of
esophageal pressure curves showed a concomitant signif-
icant reduction of respiratory rate, esophageal inspiratory
pressure swing (dPes), and esophageal pressure–time
product (PTPes) with the onset of NIV, indicating off-
loading of respiratory muscles.
The developing lung survives in a hostile environ-
ment. Research into aspects of lung development and the
pathophysiology of neonatal lung disease continues to
thrive. In an in vitro study, De Luca et al. [74] studied the
activity of secretory phospholipase A2 (sPLA2) in bron-
choalveolar lavage ﬂuid obtained from neonates and
infants with healthy lungs to which were added varying
concentrations of bile acids. They found that high con-
centrations of bile acids increased sPLA2 activity, leading
to increased surfactant catabolism. The authors conclude
that aspiration of ﬂuid containing bile acids may con-
tribute to the development of lung injury. Vento et al.
[75] also studied peptidomic proﬁles in bronchoalveolar
lavage ﬂuid obtained on day 3 of life from premature
(B32 weeks gestation) infants representing two groups,
those with and those without bronchopulmonary dysplasia
(BPD). Six peptides, found to be albumin fragments, were
found in signiﬁcantly higher levels in the BPD group than
in control patients. Levels of the matrix metalloprotein-
ase-3 (MMP-3) enzyme were also found at signiﬁcantly
higher concentrations in BPD patients. This is an
exploratory study and does not lead to any speciﬁc
mechanistic conclusion, however these authors have
shown that peptidomic techniques can be effectively
applied to the study of proteolytic enzymes from small
babies. Finally, to conclude the neonatal–surfactant
theme, Janssen et al. [76] studied endogenous surfactant
metabolism in neonates with severe respiratory failure as
a result of congenital diaphragmatic hernia (CDH) and
control neonates without signiﬁcant lung disease. The rate
of incorporation of a stable carbon-13 isotope into phos-
phatidylcholine (PC) was measured from tracheal
aspirates, and PC levels measured from epithelial lining
ﬂuid. The results showed that infants with severe respi-
ratory failure associated with CDH have decreased
surfactant PC synthesis, and the authors speculate that this
may be linked to the pathogenesis of severe pulmonary
insufﬁciency.
One paper in particular was enthusiastically welcomed
by the pediatric editorial team. Sun et al. [77] from
Shanghai, China, submitted an interesting descriptive
study on the epidemiology and reported outcomes of
ARDS (1994 American–European deﬁnitions) in children
treated in 25 pediatric ICUs in the Peoples Republic of
China. Of 12,018 admissions analyzed, 1.44% developed
ARDS, of which 61% died. The authors conclude that
different management of pneumonia and sepsis, and
ventilatory strategies will hopefully lead to reduction of
this relatively high case fatality rate. The importance of
the paper for the Journal, however, is not so much the
clinical report itself, but the joining together through
publication of the pediatric intensive care communities of
the West and the East, and the editorial board very much
hope that there will be further opportunities to publish
high-quality work from Asia and other areas of the
developing world.
Cardiovascular drugs, new and old, continue to gen-
erate interest in pediatric critical care. Baldasso et al. [78]
presented a randomized pilot study of low-dose vaso-
pressin in the support of nonseptic critically ill children
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was associated with marked falls in serum sodium con-
centration and urine output. Although systemic arterial
blood pressure rose signiﬁcantly in the vasopressin chil-
dren (n = 12) compared with saline control (n = 12), use
of vasopressin did not avoid the need for treatment with
additional vasoactive agents. It is difﬁcult to be enthusi-
astic about the further exploration of prophylactic
vasopressin in nonseptic children given the high incidence
of important side-effects and lack of clear beneﬁt.
Unknown effects of a commonly used drug were also
revealed in the study of Wong et al. [79], who investi-
gated the inﬂuence of dopamine (DOPA) on the
relationship between cerebral perfusion and metabolism
in preterm infants treated with dopamine using near-
infrared spectroscopic measurements. Cerebral fractional
oxygen extraction (CFOE) and cerebral blood ﬂow (CBF)
showed strong negative correlation in the control infants,
but not in the DOPA group. CSvO2 was lower at
decreased CBF in the control infants, but not in the DOPA
group. These results suggest a previously unrecognized
role of exogenous dopamine in preterm infants who,
uniquely, have an absence of ﬂow–metabolism coupling
together with an immature blood–brain barrier (BBB) that
allows dopamine to enter the brain parenchyma, thus
restoring ﬂow–metabolism coupling.
Three papers addressed aspects of pediatric cardiac
intensive care. Lo et al. [80] reported on the performance
of a postoperative cardiac resuscitation simulation train-
ing scheme speciﬁcally tailored to encompass scenarios
and skills required in the pediatric cardiac ICU. High-
ﬁdelity simulators are increasingly recognized as valuable
tools in the training of individuals and medical teams [81]
borrowing from experience of safety training and crew
resource management from aviation and similar high-
resilience industries. Breuer et al. [82] investigated the
potential role of acid-stimulating factors such as gastrin
and L-type amino acids in the pathogenesis of stress ulcers
in children following cardiac surgery. The most potent
acid-stimulating factor, gastrin, showed signiﬁcant ele-
vation in all patients undergoing open heart surgery.
Histidine, the most potent acid-stimulating amino acid,
was elevated only in surgery including cardiac arrest.
Interesting as these ﬁndings are, there are a large number
of other known factors, including gastric and speciﬁcally
mucosal blood ﬂow oxygenation, which were not assessed
in this study but which are likely to be clinically relevant
to the onset of gastric mucosal erosions and ulceration.
Jackman et al. [83] also looked at the phenomenon, late-
onset hyperlactatemia (LOH) in children 2–16 years of
age following cardiac surgery. They followed arterial
blood gas, and plasma lactate and glucose for up to 12 h
postoperatively. All patients studied had initial plasma
lactate values \3 mmol/l. The ﬁndings of this study
suggest that late rise in blood lactate concentration is
relatively common, occurring in 44% of 44 children
undergoing Fontan operations and in 25% of those
undergoing other types of cardiac surgery. The investi-
gators could detect no relationship between occurrence of
LOH and clinical outcomes including clinical diagnosis of
low cardiac output, inotrope score, or renal function. The
strong association observed between LOH and hypergly-
cemia is in keeping with the ﬁndings of Maillet [84] from
an adult population.
Tissue oxygenation is more easily measured as
spectroscopic techniques evolve. Wong et al. [85] eval-
uated the simultaneous measurements of CBF (Doppler
ultrasound) and spectroscopically acquired tissue oxy-
genation index (TOI) in newborn lambs (n = 8). This
study demonstrated TOI to be concordant with changes
in CBF during induced mild to moderate hypotension.
This concordance supports clinical use of TOI in study-
ing ﬂuctuations in cerebral hemodynamics with
physiological changes and clinical interventions in pre-
term infants, when arterial oxygen saturation and
cerebral oxygen consumption remain constant during the
measurement. Lee et al. [86] studied the utility of using
co-administration of N-acetyl cysteine (NAC) (a scav-
enger of reactive oxygen species) and N(G)-
monomethyl-L-arginine (a nitric oxide synthase inhibitor)
in achieving hemodynamic recovery following hypoxia-
induced myocardial injury. Whilst this study conﬁrmed
the beneﬁt previously shown for NAC, no additional
beneﬁt occurred when the nonselective nitric oxide syn-
thase inhibitor was administered.
The area of shock and its pathophysiology and man-
agement continues to elicit great research and clinical
interest. Poomthavorn and colleagues [87] evaluated
adrenal function in critically ill children using total cor-
tisol (TC), free cortisol (cFC), and the free cortisol index
(FCI). Basal and peak TC, FCI, and cFC of critically ill
children were signiﬁcantly higher than those of controls,
however elevations in basal and peak FCI and cFC were
greater than those for TC. FCI and cFC appear to better
reﬂect the dynamic changes of adrenal function of criti-
cally ill children than does TC alone. Akker et al. [88]
studied glucocorticoid receptor (GR) mRNA levels on
day 0, 3, and 7 and during recovery. They determined that
there was a transient depression of GR mRNA on day 0
compared with recovery. This may, as the authors
hypothesize, reﬂect a tissue-speciﬁc response during
sepsis leading to increased cortical resistance of neutro-
phils. Further work in the area of GC receptor kinetics is
likely to improve our understanding of pediatric sepsis
and is an attractive ﬁeld for further research. Khemani
et al. [89] described a severity score for use in children
with disseminated intravascular coagulation (DIC). They
determined that DIC score of C5 (severe DIC) in their
population of children \18 years with sepsis was asso-
ciated with a mortality rate of 50% compared with 20%
with a lower DIC score, regardless of initial severity of
illness (assessed by PIM 2 and PRISM3) or inotrope use.
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racy of neutrophil and monocyte CD64 indices for
diagnosis of sepsis in critically ill neonates and children
with established markers lipopolysaccharide binding
protein (LBP), C-reactive protein (CRP), and procalcito-
nin (PCT). The authors reported the highest diagnostic
accuracy for sepsis on the ﬁrst day of suspected sepsis in
their study was achieved by LBP in neonates and by
CD64 in children, and 24 h later by CD64 in neonates and
children. The importance of this study is to emphasize
that gold-standard septic markers may change between
age groups, and their usefulness, particularly to support
exclusion of sepsis, needs to take account of studies such
as this.
Rey et al. [91] reported a nice, simple prospective
study of mechanical complications associated with
placement of central venous catheters (CVC) in a pedi-
atric intensive care unit. Eight hundred twenty-ﬁve
catheters were placed in 546 children, having a median
age of 22 months. Two hundred ninety-three (35.5%)
catheters were sited in the internal jugular, 116 (14.1%)
subclavian, and 416 (50.4%) in femoral veins. The most
common early mechanical complications were arterial
puncture (n = 60; 7.2%), catheter malposition (n = 39;
4.7%), arrhythmias (n = 19; 2.3%), and hematoma
(n = 12; 1.4%). Resident failure to perform CVC, high
venous access (subclavian or jugular), and number of
attempts were independently associated with early
mechanical complications (EMC). The value of this study
is its sequential and prospective nature, providing as it
does a contemporary snapshot, against which others may
wish to benchmark, especially as ultrasound guidance for
catheter placement becomes more frequent.
Studies by Latour et al. [92] and Vivian et al. [93]
focus our attention on the holistic elements of critical
care. Latour reported on the use of a multicentre study
conducted in seven Dutch PICUs in which parents of
critically ill children were asked at follow-up to rate their
satisfaction with care received. Studies such as this will
allow care to be delivered in ways which are not only
clinically safe and effective, but also in ways which best
match parental expectations, enhancing collaboration
between parents and the PICU clinical team. Vivian et al.
assessed the care-giving practices of health-care practi-
tioners in the PICU using qualitative research
methodologies. All staff members were active collabora-
tors and were encouraged to describe problems with
respect to relationships, trust, and decision-making within
care-giving practices. The study qualitatively describes
how poor communication amongst staff members in
respect of relationships and decision-making impacted on
trust and how this can compromise clinical practices in
the PICU. The strength of the study was that the partici-
patory design allowing staff members to address the very
dynamics that they themselves cited as problematic,
rather than the ‘‘observational’’ or ‘‘questionnaire’’ and
similar techniques typically deployed in quantitative
research in this area.
Ethics
This section encompasses two main areas: ethics and
regulation of clinical research, and end of life in the ICU.
Ethics and regulation of clinical research
Obtaining informed consent from critically ill patients
remains a conundrum, from ethical as well as legal per-
spectives. Scales et al. [94], from Canada, surveyed 240
patients who were survivors of critical illness. Four sce-
narios of clinical trials with different possibilities for
consent were submitted to participants, who were asked to
choose the one they found acceptable or not to them. The
main ﬁnding that a vast majority (90%) of them favored
consent granted by a substitute decision-maker (SDM) is
certainly encouraging and should guide lawmakers.
However, it is noteworthy that, when the scenario
described an emergency situation in which no SDM was
present, only 25% of respondents accepted a waiver of
consent. However, a majority of them chose or were
neutral regarding delayed consent. Burns et al. [95]
challenge again the concept of SDM consent for research
in emergency situations. They quote several studies which
have demonstrated that the requirement for SDM consent
may slow the accrual rate or even stop important trials.
They argue that too restrictive regulations intended to
protect patients may in fact be a ‘‘disservice’’ to this
population.
The functioning of Research Ethics Committees
(REC) is also a burning issue. Daniel Pehboeck et al. [96]
from Innsbruck, Austria, made an online survey of
investigators from European Union (EU) member states
(n = 193), with the aim of quantifying the level of
(dis)satisfaction regarding several administrative con-
straints. Respondents gave negative ratings to all aspects
of the role and actual services provided by RECs. In two
papers coming from Austria, prominent members of the
Ethics Committee of the Medical University of Vienna
gave additional insights into European RECs. Druml et al.
[97] provide a comprehensive view of the situation of EU
RECs, 5 years after the implementation of directive 2001/
20/EC in national legislations. They review the compo-
sition of RECs, the number of members, the number of
committees per country (from 40 in France to 264 in
Italy), and other characteristics. In another article, the
same group [98] describe a process they implemented in
their REC to deal with the mounting ﬂux of protocols they
are dealing with. An expedited review allows a research
project to be examined by a subgroup of members of the
578committee, in order to streamline the process. To be eli-
gible for such ‘‘fast-track’’ review, protocols must entail
only ‘‘minimal risks’’ to participants. In an editorial to
these two papers, Chassany [99] reminds us that the EU
directive and all provisions it sets up cover only the area
of drug research, and that the rest of clinical research, on
medical devices, surgery, pathophysiology, etc., is totally
left out. This is a major cause for the heterogeneity of
ethical review within the EU. Additionally, he appeals to
the recognition within the directive 2001/20/EC of a
simpliﬁed track for research with only ‘‘minimal risk’’.
This is a major issue for the revision of the directive,
expected for 2011.
End of life in the ICU
Family satisfaction is a recognized marker of quality-of-
care assessment. Stricker et al. [100] analyzed 996
questionnaires ﬁlled in by family members of ICU
patients in German-speaking Switzerland. Globally, care
and information/decision-making items had rather high
rates. Not very surprisingly, family satisfaction had low
rates when the patient-to-nurse ratio was high. Interest-
ingly, higher simpliﬁed acute physiologic score (SAPS)
scores were correlated with higher satisfaction with care.
However, there is some room for improvement: poor
grades were given concerning the lack of waiting room,
short visiting hours, and information only on demand,
giving useful indications where efforts should be directed.
On the same line, Fumis [101] investigated the levels of
anxiety and depression of families of cancer patients
admitted to an ICU in Brazil. They found a high degree of
anxiety (71% of families) and of depression (75%).
Organizational items were not tested in this study.
Going home to die (GHTD) is supposed to be a uni-
versal demand, though it is rarely achieved or even
envisaged. However, some ICUs, probably from speciﬁc
cultures/ethnicities, succeeded in making it possible.
Huang et al. [102] report from a single institution in
Taiwan how going home to die is achieved as frequently as
in 44% (in 2003; a decline over time—25% in 2007—is
not commented on by the authors) according to cultural/
religious Chinese traditions. It is related to older age,
married status, and no do not resuscitate (DNR). From an
editorial viewpoint, this paper shows how informative and
useful single-center studies can be, at odds with most
editorial policies, which praise most multicenter ones. In a
joint editorial, Kompanje [103] insists on the feasibility of
the process, which necessitates a specialized transporta-
tion system, apparently existing in The Netherlands. The
GHTD procedure is also mentioned in a paper by Mani
et al. [104], which describes the end-of-life decisions in an
Indian ICU (also a single ICU report). However, the
context here is markedly different: out of the 48 deaths
with treatment limitation, 38 (79%) were discharged
terminally athome as ‘‘left againstmedical advice,’’ due to
ﬁnancial reasons. The authors specify that this practice has
now disappeared from their ICU. Azoulay et al. [105]
have used the SAPS 3 database to identify organizational
predictors of decisions to forgo life-sustaining therapies
(DFLST). Todoso, theyanalyze data from14,488patients
admitted to 303 ICUs, out of which 1,239 (8.6%) had a
DLFST. They demonstrated that, besides characteristics
linked to patients or countries, organizational factors
indeed play asigniﬁcant role.For instance, thedecisions to
forgo LS therapies appeared more common in hospitals
without an emergency department, in smaller ICUs, and in
ICUs with a lower nurse-to-patient ratio. DFLSTs were
less frequent in ICUs that had at least one full-time in-
tensivist and when they were not available at night or
during weekends, which is certainly disturbing at ﬁrst
sight and deserves to be further explored.
Italy remains a country in which decisions at the end
of life are still ﬁercely debated. Striano et al. [106] come
back to the Eluana Englaro story, which ignited the
peninsula in 2008. They show how withdrawal of ﬂuids
and nutrition for patients in permanent vegetative states is
still a difﬁcult issue, confused with cultural and religious
beliefs.
Brain death and organ donation
Brain death and organ donation are also a matter of major
interest for intensivists and directly impact on ICU
workload. Joffe et al. [107] surveyed medical and nursing
students in a medical ethics class, and philosophy students
in Canada. They tested their knowledge and basic
understanding concerning brain death reality and donation
legitimacy. The results are appalling. After presentation
of a scenario of a brain death patient, 50% (students who
were given brief information) to 65% (those who received
detailed information) of them were not convinced that the
patient (the donor) was really dead. In the same area,
Zamperetti and Bellomo [108], in a thoughtful comment
to a white paper of the US Council of Bioethics published
in December 2008, draw our attention to the possible
evolution of the deﬁnition of ‘‘brain death’’ which could
impact our practice.
Miscellanea
Cost, the elderly, cancer, and glycemic control
Niskanen et al. designed an observational cohort study
(63,304 patients in 23 Finnish ICUs) to create a tool for
benchmarking with respect to case-mix-adjusted length of
stay (LOS) and to study the association between clinical
and economic measures of ICU performance [109].
579Linear regression was used to create a model that pre-
dicted ICU LOS. There was no association between the
mean observed–mean expected ICU length of stay and
standardized mortality ratios of the ICUs.
Sacanella et al. recruited prospectively 230 patients
C65 years living at home, with full autonomy, without
cognitive impairment, and admitted to a medical ICU
[110]. Over a mean follow-up of 522 days (range 20–
1,170 days) the cumulative mortality of the whole group
was 55%, being signiﬁcantly higher in the 120 subjects
older than 75 years (62% versus 47%; P = 0.024). On
multivariate analysis, only parameters related to quality of
life and functional status were independent predictors of
cumulated mortality.
In a prospective study, McLaughlin et al. assessed the
cost of 64 consecutive admissions to an adult ICU using
bottom-up costing methodology and evaluate the useful-
ness of ‘‘severity of illness’’ scores in estimating ICU cost
[111]. The median daily ICU cost was 2,205 euros
(1,932–3,073 euros), and the median total ICU cost was
10,916 euros (4,294–24,091 euros). ICU survivors had a
lower median daily ICU cost compared with ICU non-
survivors. Requirements for continuous hemodiaﬁltration,
blood products, and antifungal agents were associated
with higher daily and overall ICU costs. Each point
increase in SAPS3 was associated with an increase in total
ICU cost. A model including hemodiaﬁltration, blood
products, and antifungal agents explained 54% of the
variance in total ICU cost.
Oliver et al. identiﬁed associations among hemoglobin
(Hb) concentrations, blood transfusions, and clinical
outcomes in 1,216 patients who underwent valve
replacement or bypass surgery [112]. Organ dysfunction,
ICU length of stay, and mortality were higher in the two
lower quartiles of minimal hemoglobin. Mortality was
higher in patients transfused C4 packed red cells (PRCs).
Patients who underwent bypass surgery when they had Hb
B8.9 g/dL and those who underwent valve replacement
when they had Hb [8.9 g/dL and were transfused C4
PRCs had higher mortality.
Roques et al. studied 6-month outcomes in 105
patients with extensive lung cancer [113]. ICU admission
was required for acute respiratory failure in 59% of the
cases. ICU, hospital, and 6-month mortality rates were
43%, 54%, and 73%, respectively. Cancer progression
and the need for mechanical ventilation were indepen-
dently associated with 6-month mortality. Two-thirds of
the ICU survivors were able to receive anticancer
treatment.
An optimal target for glucose control in ICU patients
remains unclear. Preiser and Coll [114] published a pro-
spective randomized controlled trial comparing the effects
on ICU mortality of intensive insulin therapy (IIT) with
an intermediate glucose control.
From 1,101 admissions, the outcomes of 542 patients
assigned to group 1 [target blood glucose (BG) 7.8–
10.0 mmol/L] and 536 patients assigned to group 2
(target BG 4.4–6.1 mmol/L) were analyzed. The groups
were well balanced. BG levels averaged in group 1
8.0 mmol/L (IQR 7.1–9.0) (median of all values) and
7.7 mmol/L (IQR 6.7–8.8) (median morning BG) versus
6.5 mmol/L (IQR 6.0–7.2) and 6.1 mmol/L (IQR 5.5–
6.8) for group 2 (P\0.0001 for both comparisons). The
percentage of patients treated with insulin averaged
66.2% and 96.3%, respectively. Proportion of time spent
in target BG was similar, averaging 39.5% and 45.1%
[median (IQR) 34.3% (18.5–50.0%) and 39.3% (26.2–
53.6%)] in groups 1 and 2, respectively. The rate of
hypoglycemia was higher in group 2 (8.7%) than in
group 1 (2.7%, P\0.0001). This trial was prematurely
stopped due to a high rate of unintended protocol vio-
lations, and therefore the study was underpowered. The
authors concluded that ICU mortality was similar in the
two groups (15.3% versus 17.2%), with the lack of
clinical beneﬁt of intensive insulin therapy (target 4.4–
6.1 mmol/L), associated with increased incidence of
hypoglycemia, as compared with a 7.8–10.0 mmol/L
target.
ICU-acquired events
Calvino Gu ¨nther et al. evaluated the incidence of unin-
tended tube, line, and drain removals and identiﬁed
system factors associated with these events [115]. Of
2,007 admitted patients, 193 (9.6%) experienced 270
events (22/1,000 patient days). Admission for coma and
mechanical ventilation were associated with iatrogenic
events. SAPS II[45 was protective from iatrogenic
events. A continuous quality improvement program
allowed a 67.4% drop in the iatrogenic rate.
Pleural effusions are common in ICU patients. Liang
et al. [116] retrospectively assessed efﬁcacy and compli-
cations of ultrasound-guided pigtail catheter drainage of
pleural effusions in ICU. Thoracic empyema and massive
transudative effusions were the main reasons for drainage.
Drainage of massive transudative effusion yielded the
largest amount of ﬂuid, provided the longest duration of
drainage, but also had the highest complication rate.
Success rate was the highest with traumatic hemothorax
and the lowest with empyema. No signiﬁcant insertion
complications were observed. The authors concluded that
this technique is well tolerated and effective for draining
pleural effusions in ICU.
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